In continuation to letter dated 15th February, 2022, regarding approval of Audited Financial Results for quarter and year ended 31st March, 2022; Welcure Drugs & Pharmaceuticals has informed that it enclosed the newspaper advertisement published, in compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in Financial Express (English) and Jansatta (Hindi) on 16th April, 2022.
The above information is a part of company’s filings submitted to BSE.